Ten63 Therapeutics

📍 Durham, United States🗓 Founded 2018👥 25 employees💰 Last funded Jan 2021
Biotechnology Research🌐 ten63tx.com
Website LinkedIn
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance. At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply directly via LinkedIn or our website. We do not post job openings at other sites. Job seekers at Ten63 please check our website for additional information. https://www.ten63tx.com/job-seekers-announcement
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Ten63 Therapeutics?
Ten63 Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Ten63 Therapeutics last raise funding?
The most recent investment in Ten63 Therapeutics recorded on gritt.io was in January 2021.
When was Ten63 Therapeutics founded?
Ten63 Therapeutics was founded in 2018.
What industry is Ten63 Therapeutics in?
Ten63 Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ten63 Therapeutics based?
Ten63 Therapeutics is headquartered in Durham, United States.